 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 5 | 1/1 | 返回列表 |
| 查看: 1616 | 回復(fù): 7 | |||
| 當(dāng)前只顯示滿足指定條件的回帖，點(diǎn)擊這里查看本話題的所有回帖 | |||
如貓似狗金蟲 (正式寫手)
|
[交流]
一篇中藥成分活性的綜述英文手稿sci秒拒11回還有什么期刊可推薦試試？ 已有2人參與
|
||
|
大概1萬字。拒稿11次，都沒送審過，想再找一個sci期刊試試，如果還不行就打算試投普刊了。 1.ARCHIV DER PHARMAZIE，IF5.1，免費(fèi)，年文章數(shù)164，rejected 2. PHYTOTHERAPY RESEARCH，IF7.2，免費(fèi)，年文章數(shù)323，rejected 3.Fitoterapia，IF3.4，免費(fèi)，年文章數(shù)214，收綜述，rejected 4.Planta medica，拒稿 5.Phytomedicine，拒稿 6.Journal of TCM，拒稿 7.Frontier in pharmacology，拒稿，文中引文是作者年，文獻(xiàn)列表是作者字母順序 8.CNMJ, 拒稿，文中引文是數(shù)字，文獻(xiàn)列表也是數(shù)字 9.Applied Sciences，拒稿，文中引文是數(shù)字，文獻(xiàn)列表也是數(shù)字 10.Journal of Ethnopharmacology，拒稿 11.The American Journal of Chinese Medicine，拒稿 |
回復(fù)此樓» 猜你喜歡
材料化工調(diào)劑
已經(jīng)有17人回復(fù)
-
312求調(diào)劑
已經(jīng)有8人回復(fù)
-
304分材料專碩求調(diào)劑
已經(jīng)有10人回復(fù)
-
主編終審卡者不動
已經(jīng)有3人回復(fù)
-
085600 材料與化工 298
已經(jīng)有13人回復(fù)
-
0856材料與化工，270求調(diào)劑
已經(jīng)有16人回復(fù)
-
080500材料科學(xué)與工程
已經(jīng)有6人回復(fù)
-
320材料與化工，求調(diào)劑
已經(jīng)有5人回復(fù)
-
成果系統(tǒng)訪問量大，請15分鐘后再嘗試。由此給您造成的不便，敬請諒解。
已經(jīng)有12人回復(fù)
-
281求調(diào)劑
已經(jīng)有5人回復(fù)
TopEdit
銅蟲 (著名寫手)
- 應(yīng)助: 184 (高中生)
- 金幣: 4223
- 帖子: 1111
- 在線: 32.2小時
- 蟲號: 35566815
- 注冊: 2024-08-01
- 專業(yè): 食品科學(xué)基礎(chǔ)
3樓2024-11-25 13:49:38
linjunc
金蟲 (正式寫手)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 1266.6
- 帖子: 578
- 在線: 17.6小時
- 蟲號: 33613141
- 注冊: 2023-04-16
- 專業(yè): 太陽和太陽系
★
小木蟲: 金幣+0.5, 給個紅包，謝謝回帖
小木蟲: 金幣+0.5, 給個紅包，謝謝回帖
|
綜述一般邀稿才容易接受，特別是免費(fèi)期刊本來刊文就少。建議投發(fā)文量大的期刊，合作的話可能可以報(bào)銷版面費(fèi) 發(fā)自小木蟲手機(jī)客戶端 |
2樓2024-11-22 20:26:01
如貓似狗
金蟲 (正式寫手)
- 應(yīng)助: 20 (小學(xué)生)
- 金幣: 2312.9
- 散金: 170
- 紅花: 3
- 帖子: 521
- 在線: 214.7小時
- 蟲號: 1177656
- 注冊: 2010-12-26
- 性別: GG
- 專業(yè): 天然有機(jī)化學(xué)
|
就Frontier in pharmacology給了些意見，我粘上來：The reason for this decision is: The content of this manuscript does not meet the standards of scientific quality or rigor required by the journal to be considered for peer review.質(zhì)量和嚴(yán)謹(jǐn)性不過關(guān) Thank you for this MS手稿, which certainly 當(dāng)然，無疑is within our scope and potentially interesting. However, the review process has identified a series of further concerns. 綜述過程有問題，有大問題There are major concerns and therefore, we cannot send your MS our to peer-review and we must reject your MS. The AE副編輯 highlighted: In its current form the MS in essence descriptive and a more critical analysis of the evidence. @@@現(xiàn)在手稿是描述性的，應(yīng)該更加批判性的。What do the data you review show and what not 文獻(xiàn)給出什么，沒有給出什么(i.e. limitations, problems in the design of the studies and future research needs? @@@實(shí)驗(yàn)設(shè)計(jì)的局限性和問題是什么？將來研究方向？Please note: @@@If pharmacological studies are reviewed, we expect some information on the dose range tested劑量范圍, the minimal active concentration最小有效濃度, the model used (incl. information whether it is an in vitro or in vivo study), if and what controls (incl positive and negative陽性對照和陰性對照) were used, duration, type of extract used as well as other basic pharmacological data. The same is in essence true for clinical studies. Often pharmacological activities are reported very naively天真和幼稚，有些paper爛, and such papers are especially common in journals with no or poor peer-review. This ranges from simple points like a use of appropriate controls and the full taxonomic validity分類學(xué)有效性 of the material under investigation (see also below), to the relevance of the model模型與所研究問題相關(guān)性 for the question being researched (e.g. can specific in silico or in vitro models really say s.th. about the species anti-inflammatory activity?例如計(jì)算機(jī)模擬或者體外模型能夠說明物種的抗炎活性嗎). Reviews must provide a specific and critical (!!) assessment of the literature. 綜述必須對文獻(xiàn)進(jìn)行具體和批判性的（�。。┰u估。The scientific quality of the original articles must be critically assessed. 文獻(xiàn)的質(zhì)量必須嚴(yán)格評估。This includes the experimental design, and reliability of the studies研究的可靠性including a sufficiently detailed definition of the material under investigation. A description of the limitations and future research needs and priorities優(yōu)先事項(xiàng)，當(dāng)務(wù)之急 must be included.必須包括對局限性和未來研究需求和優(yōu)先事項(xiàng)的描述。 |
4樓2024-11-27 16:10:40
如貓似狗
金蟲 (正式寫手)
- 應(yīng)助: 20 (小學(xué)生)
- 金幣: 2312.9
- 散金: 170
- 紅花: 3
- 帖子: 521
- 在線: 214.7小時
- 蟲號: 1177656
- 注冊: 2010-12-26
- 性別: GG
- 專業(yè): 天然有機(jī)化學(xué)
5樓2024-11-27 16:19:06
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 085600 材料與化工 298 +13 | 小西笑嘻嘻 2026-03-03 | 13/650 |
|
|---|---|---|---|---|
|
|
[考研] 求調(diào)劑 +5 | 博斯特525 2026-03-04 | 5/250 |
|
|
|
[考研] 322,求調(diào)劑 +3 | 菜菜愛玩 2026-03-04 | 3/150 |
|
|
|
[考研] 中國科學(xué)技術(shù)大學(xué)材料與化工281求調(diào)劑，有科研和獲獎經(jīng)歷 +9 | wsxw 2026-03-02 | 10/500 |
|
|
[考研] 0703化學(xué)調(diào)劑 +4 | G212 2026-03-03 | 5/250 |
|
|
|
[考研] 0703 總分319求調(diào)劑 +4 | Xinyuu 2026-03-02 | 4/200 |
|
|
|
[考研] 291求調(diào)劑 +4 | Afy123456 2026-03-03 | 7/350 |
|
|
|
[考研] 085600材料與化工調(diào)劑 280分 +10 | yyqqhh 2026-03-03 | 10/500 |
|
|
|
[碩博家園] 2025屆雙非化工碩士畢業(yè)，申博 +4 | 更多的是 2026-02-27 | 5/250 |
|
|
|
[考研] 289求調(diào)劑 +7 | BrightLL 2026-03-02 | 9/450 |
|
|
|
[考研] 成績276，專業(yè)代碼0856求調(diào)劑 +7 | 小陳朵 2026-03-03 | 7/350 |
|
|
|
[考研] 材料學(xué)碩318求調(diào)劑 +11 | February_Feb 2026-03-01 | 11/550 |
|
|
|
[考研] 299求調(diào)劑 +5 | kkcoco25 2026-03-02 | 9/450 |
|
|
|
[考研] 調(diào)劑 +5 | 13853210211 2026-03-02 | 7/350 |
|
|
|
[考研] 338求調(diào)劑 +5 | 18162027187 2026-03-02 | 6/300 |
|
|
|
[考研] 【2026 碩士調(diào)劑】課題組 招收調(diào)劑生 +3 | 考研版棒棒 2026-03-02 | 5/250 |
|
|
|
[考研] 275求調(diào)劑 +7 | 明遠(yuǎn)求學(xué) 2026-03-01 | 7/350 |
|
|
|
[考研] 303求調(diào)劑 +5 | 今夏不夏 2026-03-01 | 5/250 |
|
|
|
[基金申請] 此成果不能導(dǎo)入原因：元數(shù)據(jù)必填信息不完整，可 進(jìn)行補(bǔ)充。 +4 | Kittylucky 2026-03-02 | 5/250 |
|
|
|
[考研] 調(diào)劑 +3 | 13853210211 2026-03-02 | 4/200 |
|